Selvita presents at BIO-Europe 2017

Kraków, Poland – 06 November 2017 – Selvita is participating and presenting at the BIO-Europe 2017 conference, taking place on November 6-8, 2017, in Berlin, Germany. Selvita will be presenting in the Oncology category. The presentation will be held by Mr. Pawel Przewiezlikowski, Chief Executive Officer at Selvita, on November 8, at 10:15 am…

More

Selvita exhibits at the 35th Medicinal Chemistry Symposium in Japan

Kraków, Poland – 18  October 2017 – Selvita will participate in and exhibit during the upcoming 35th Medicinal Chemistry Symposium, which will take place in Nagoya, Japan, October 25 – 27, 2017. This symposium provides superb opportunities for participants to expand scientific knowledge and information on medicinal chemistry, and also to…

More

Selvita researchers and academic collaborators demonstrate the potential of MNK1/2 kinase inhibitors in the treatment of c-Kit positive melanomas

Krakow, Poland – 17 October 2017 – Researchers from Selvita, a biotechnology company focused on innovative medicines for oncology patients and drug discovery services, in collaboration with scientists from the McGill University, Université Libre de Bruxelles and Peking University Cancer Hospital & Institute, have jointly published a research paper validating…

More

Selvita presents at the 4th Drug Discovery USA Congress

Krakow, Poland – 05 October 2017 – Selvita is a proud sponsor of the upcoming 4th Drug Discovery USA Congress which will take place on October 09 -10, 2017, in San Diego, CA. This event will gather over 250 delegates representing leading biotech companies, global pharmaceutical organisations and internationally renowned…

More

...23456...10...